에서 실시간으로 운영 중이에요! 자세히 알아보기
NAII 아이콘

Natural Alternatives International

1.15 USD
+0.03
2.68%
장 마감 시점 업데이트됨 10월 16일 PM 4:00 EDT
1일
2.68%
5일
1.77%
1개월
-41.33%
3개월
-49.12%
6개월
-57.25%
연초 이후
-67.97%
1년
-57.25%
5년
-91.42%
10년
-91.61%
 

소개: Natural Alternatives International Inc is formulator, manufacturer and marketer of nutritional supplements. Its comprehensive strategic partnerships with its customers allow to offer a wide range of nutritional products and services to such customers including scientific research, clinical studies, proprietary ingredients, customer-specific nutritional product formulation, product testing and evaluation, marketing management and support, packaging and delivery system design, regulatory review, and international product registration assistance. It has two segments Private-label contract manufacturing, and Patent and trademark licensing. Majority of revenue comes from Private-label contract manufacturing. Majority of revenue comes from United States.

직원 수: 230

뉴스

긍정적
중립
부정적
투자 심리 3개월
긍정적 33.3%
중립 66.7%
부정적 0%
중립
Zacks Investment Research
17일 전
Natural Alternatives Q4 Loss Widens Y/Y on Margin Pressure
NAII posts y/y sales growth in Q4'26, but a $10.4M impairment charge and factory underutilization weigh on profitability.
Natural Alternatives Q4 Loss Widens Y/Y on Margin Pressure
중립
GlobeNewsWire
18일 전
Natural Alternatives International, Inc. Announces Fiscal 2026 Q4 and YTD Results
CARLSBAD, Calif., Sept. 28, 2026 (GLOBE NEWSWIRE) -- Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), a leading formulator, manufacturer, and marketer of customized nutritional supplements, announced today a net loss of $13.5 million, or ($2.23) per diluted share, on net sales of $34.5 million for the fourth quarter of fiscal year 2026 compared to a net loss of $7.2 million, or ($1.20) per diluted share, in the fourth quarter of the prior fiscal year. Our net loss for the fourth quarter of fiscal 2026 includes a non-recurring non-cash charge of $10.4 million related to the impairment of our Carlsbad, CA manufacturing facility due to its underutilization. Excluding this charge, our net loss for the fourth quarter of fiscal 2026 would have been $3.1 million, or ($0.52) per diluted share.
Natural Alternatives International, Inc. Announces Fiscal 2026 Q4 and YTD Results
긍정적
Zacks Investment Research
2개월 전
3 Microcaps for Your Watchlist
NHTC, HCWC, and NAII sell into the growing nutrition and wellness space.
3 Microcaps for Your Watchlist
긍정적
Benzinga
3개월 전
Top 3 Risk Off Stocks That May Rocket Higher In Q3
The most oversold stocks in the consumer staples sector presents an opportunity to buy into undervalued companies.
Top 3 Risk Off Stocks That May Rocket Higher In Q3
부정적
Zacks Investment Research
4개월 전
Natural Alternatives Q3 Loss Widens Y/Y on Margin Pressure
NAII's Q3 sales rise 23% y/y, but a wider loss and margin pressure offset gains from stronger contract manufacturing demand.
Natural Alternatives Q3 Loss Widens Y/Y on Margin Pressure
중립
GlobeNewsWire
5개월 전
Natural Alternatives International, Inc. Announces 2026 Q3 and YTD Results
CARLSBAD, Calif., May 19, 2026 (GLOBE NEWSWIRE) -- Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), a leading formulator, manufacturer, and marketer of customized nutritional supplements, today announced a net loss of $4.3 million, or $0.72 per diluted share, on net sales of $35.5 million for the third quarter of fiscal year 2026 compared to a net loss of $2.2 million, or $0.37 per diluted share, in the third quarter of the prior fiscal year.
Natural Alternatives International, Inc. Announces 2026 Q3 and YTD Results
중립
Zacks Investment Research
8개월 전
Natural Alternatives Q2 Loss Widens Y/Y, Sales Increase
NAII posts higher Q2 sales but wider losses, and trims its outlook for fiscal 2026 amid softer customer forecasts and launch delays.
Natural Alternatives Q2 Loss Widens Y/Y, Sales Increase
중립
GlobeNewsWire
8개월 전
Natural Alternatives International, Inc. Announces 2026 Q2 and YTD Results
CARLSBAD, Calif., Feb. 13, 2026 (GLOBE NEWSWIRE) -- Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), a leading formulator, manufacturer, and marketer of customized nutritional supplements, today announced a net loss of $2.6 million, or $0.42 per diluted share, on net sales of $34.8 million for the second quarter of fiscal year 2026 compared to a net loss of $2.2 million, or $0.37 per diluted share, in the second quarter of the prior fiscal year.
Natural Alternatives International, Inc. Announces 2026 Q2 and YTD Results
긍정적
Zacks Investment Research
9개월 전
Niche Focus & Regulation Shape the Future of Healthcare Firms
CPIX, NAII and ICCC lean into specialization, compliance and targeted growth to thrive in the niche healthcare markets.
Niche Focus & Regulation Shape the Future of Healthcare Firms
중립
GlobeNewsWire
11개월 전
Natural Alternatives International, Inc. Announces 2026 Q1 Results
CARLSBAD, Calif., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), a leading formulator, manufacturer, and marketer of customized nutritional supplements, today announced a net loss of $0.3 million, or $0.05 per diluted share, on net sales of $37.7 million for the first quarter of fiscal year 2026 compared to a net loss of $2.0 million, or $0.33 per diluted share, in the first quarter of the prior fiscal year.
Natural Alternatives International, Inc. Announces 2026 Q1 Results
Lightweight Charts™를 사용해 가격 차트를 구현했어요.